News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Taubert Jennifer L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Taubert Jennifer L (Director) has filed a Form 4 on MCDONALDS CORP|
Txns:
| Granted 109 options to buy
@ $263.44, valued at
$28.7k
|
|
| 07/05/2023 |
4
| Taubert Jennifer L (Director) has filed a Form 4 on MCDONALDS CORP|
Txns:
| Granted 96 options to buy
@ $298.41, valued at
$28.7k
|
|
| 04/04/2023 |
4
| Taubert Jennifer L (Director) has filed a Form 4 on MCDONALDS CORP|
Txns:
| Granted 103 options to buy
@ $279.61, valued at
$28.7k
|
|
| 01/04/2023 |
4
| Taubert Jennifer L (Director) has filed a Form 4 on MCDONALDS CORP|
Txns:
| Granted 300 options to buy
@ $263.53, valued at
$79.2k
|
|
| 11/23/2022 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Sold 76,923 shares
@ $176.7794, valued at
$13.6M
Exercised 76,923 options to buy
@ $72.54, valued at
$5.6M
|
|
| 10/07/2022 |
3
| Taubert Jennifer L (Director) has filed a Form 3 on MCDONALDS CORP |
| 02/17/2022 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 8,841 shares
@ $165.89, valued at
$1.5M
Granted 80,055 options to buy
@ $165.89, valued at
$13.3M
Granted 4,053 options to buy
@ $0
Exercised 18,064 options to buy
@ $0 |
|
| 02/15/2022 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 1,190 shares
@ $168.85, valued at
$200.9k
Exercised 3,297 options to buy
@ $0 |
|
| 02/17/2021 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 797 shares
@ $165.55, valued at
$131.9k
Paid exercise price by delivering 5,268 shares
@ $165.55, valued at
$872.1k
Exercised 11,429 options to buy
@ $0
Exercised 2,177 options to buy
@ $0 |
|
| 02/18/2020 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 3,951 shares
@ $150.46, valued at
$594.5k
Paid exercise price by delivering 4,277 shares
@ $150.46, valued at
$643.5k
Exercised 8,360 options to buy
@ $0
Exercised 7,724 options to buy
@ $0 |
|
| 02/12/2020 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Granted 91,324 options to buy
@ $151.41, valued at
$13.8M
Granted 8,360 options to buy
@ $0
Granted 3,570 options to buy
@ $0 |
|
| 02/04/2020 |
4
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 23,721 shares
@ $149.32, valued at
$3.5M
Exercised 48,312 options to buy
@ $0 |
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2018 |
3
| Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) has filed a Form 3 on JOHNSON & JOHNSON |
|
|